adesso ventures

Corporate venture funds attached to IT services firms tend to be polite and quiet, and adesso ventures is among the more disciplined examples of the type. The Berlin-based vehicle is the captive venture arm of adesso Group, the German enterprise IT services and software business, and it deploys pre-seed and seed capital into vertical software companies that touch the parent’s customer base. Healthcare features regularly in the portfolio because adesso Group itself runs a substantial healthcare IT practice in the German-speaking market, and the venture arm has used that distribution lens to back companies like Nia Health and Noah Labs. Founders engaging adesso ventures should understand they are speaking to a strategic investor with a specific commercial overlay rather than to a financial fund running a returns-only mandate.

The thesis at adesso ventures reflects its parentage. The firm invests in vertical enterprise software with an emphasis on financial services, healthcare, public sector, and the broader DACH-region enterprise stack. Healthcare exposure is concentrated in digital health and health IT, areas where the parent company can plausibly act as an integration partner, channel, or customer reference. The fund was founded in 2017 and has built a portfolio shaped less by stage-of-the-art thematic bets and more by a steady cadence of companies that fit the adesso ecosystem. Founders pitching the firm should expect questions about how the company’s product would interact with the systems integration and software work the parent already performs for hospitals, insurers, and corporate clients in Germany. Pitches that ignore the strategic angle tend to underperform; pitches that lean into it without becoming dependent on it tend to land.

The portfolio is anchored by a small number of named bets that surface consistently in the firm’s public material. Nia Health is among the more visible: a Berlin-based digital therapeutics company focused on chronic skin conditions that has built a real commercial business in the German prescription digital health market. Noah Labs sits in the cardiovascular monitoring space, applying voice biomarker technology to remote patient management. Together those two companies illustrate the firm’s preference for clinically grounded digital health products rather than consumer wellness, and for companies pursuing reimbursement and clinical-evidence pathways rather than direct-to-consumer subscription models. The firm also invests outside healthcare in vertical enterprise software, but the digital health subset is where founders considering adesso ventures will find the cleanest pattern match.

Check sizes fall in the one-to-five million dollar range, with deployment concentrated at pre-seed and seed. The firm does not typically lead Series A rounds and does not write growth-stage checks. Founders should expect adesso ventures to participate in a syndicate rather than to anchor a round alone, though leadership is possible at the earlier stages. The firm’s strategic value is most pronounced when the portfolio company can plausibly use adesso Group as a channel into German enterprise customers; founders who cannot articulate that lever should expect the relationship to feel transactional rather than partnered.

Decision-making sits within a small Berlin team with reporting lines into the parent group. That structure means decisions involve some strategic alignment with the parent’s commercial priorities, which can either accelerate or extend the diligence timeline depending on how cleanly the founder’s narrative fits adesso Group’s existing book of business.

The most effective approach is a warm introduction through a portfolio founder or a German healthcare ecosystem operator. Cold inbound is read but not prioritized. Founders should be specific about their German-market commercial strategy and should be prepared to discuss reimbursement pathways, hospital procurement, and Krankenkassen relationships in concrete terms.

Founders should know that adesso ventures is a strategic investor first and a financial investor second. Capital terms are reasonable, but the relationship’s value depends heavily on whether the parent company’s services business can act as a channel. Founders without a German-market thesis will find better-fit investors elsewhere.